Ally Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ally Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-85,000	Closed	-$7.59M	–	123
2023 Q4	$7.59M	Hold	85,000	–	–	0.99%	26
2023 Q3	$6.21M	Hold	85,000	–	–	0.91%	29
2023 Q2	$7.07M	Hold	85,000	–	–	0.99%	27
2023 Q1	$6.48M	Hold	85,000	–	–	0.96%	29
2022 Q4	$7.05M	Hold	85,000	–	–	1.1%	25
2022 Q3	$6.74M	Hold	85,000	–	–	1.11%	25
2022 Q2	$6.31M	Hold	85,000	–	–	0.86%	33
2022 Q1	$7.64M	Buy	85,000 +63,000	+286%	+$5.82M	0.88%	33
2021 Q4	$2.46M	Buy	+22,000	New	+$2.65M	0.23%	82

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ally Financial's XBI Position: Q1 2024 in Review

Ally Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 85,000 shares — an estimated $7.59M sold.

Ally Financial first reported a position in XBI in Q4 2021 and held it in 9 quarters. The position peaked at $7.64M in Q1 2022. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Ally Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Ally Financial sold 85,000 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $7.59M.
Ally Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 9 quarters.
Ally Financial's State Street SPDR S&P Biotech ETF position peaked at $7.64M in Q1 2022.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Ally Financial's 13F filing for Q1 2024, filed 14 May 2024.